Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Role of intravascular ultrasound in the detection of cardiovascular disease in diabetes and metabolic syndrome in Latin America (2016)

  • Authors:
  • USP affiliated authors: MARIN NETO, JOSE ANTONIO - FMRP
  • USP Schools: FMRP
  • DOI: 10.1007/s12410-016-9395-8
  • Subjects: ULTRASSONOGRAFIA; DOENÇAS CARDIOVASCULARES; DIABETES MELLITUS; DOENÇAS METABÓLICAS
  • Keywords: Intravascular ultrasound (IVUS); Coronary heart disease; Percutaneous coronary intervention; Diabetes mellitus; Metabolic syndrome
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s12410-016-9395-8 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s12410-016-9395-8 (Fonte: Unpaywall API)

    Título do periódico: Current Cardiovascular Imaging Reports

    ISSN: 1941-9066,1941-9074



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Current Cardiovascular Imaging Reports

    ISSN: 1941-9066

    Citescore - 2017: 0.86

    SJR - 2017: 0.34

    SNIP - 2017: 0.419


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2843793pcd 2843793 Estantes Deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LIMA FILHO, Moysés de Oliveira; BRITO JUNIOR, Fábio Sândoli de; MARIN NETO, José Antonio. Role of intravascular ultrasound in the detection of cardiovascular disease in diabetes and metabolic syndrome in Latin America. Current Cardiovascular Imaging Reports, Philadelphia, v. 9, 2016. Disponível em: < http://dx.doi.org/10.1007/s12410-016-9395-8 > DOI: 10.1007/s12410-016-9395-8.
    • APA

      Lima Filho, M. de O., Brito Junior, F. S. de, & Marin Neto, J. A. (2016). Role of intravascular ultrasound in the detection of cardiovascular disease in diabetes and metabolic syndrome in Latin America. Current Cardiovascular Imaging Reports, 9. doi:10.1007/s12410-016-9395-8
    • NLM

      Lima Filho M de O, Brito Junior FS de, Marin Neto JA. Role of intravascular ultrasound in the detection of cardiovascular disease in diabetes and metabolic syndrome in Latin America [Internet]. Current Cardiovascular Imaging Reports. 2016 ; 9Available from: http://dx.doi.org/10.1007/s12410-016-9395-8
    • Vancouver

      Lima Filho M de O, Brito Junior FS de, Marin Neto JA. Role of intravascular ultrasound in the detection of cardiovascular disease in diabetes and metabolic syndrome in Latin America [Internet]. Current Cardiovascular Imaging Reports. 2016 ; 9Available from: http://dx.doi.org/10.1007/s12410-016-9395-8

    Referências citadas na obra
    Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS): a report of the American College of Cardiology task force on clinical expert consensus documents developed in collaboration with the European Society of Cardiology endorsed by the Society of Cardiac Angiography and Interventions. J Am Coll Cardiol. 2001;37(5):1478.
    Mintz GS, Kent KM, Pichard AD, Satler LF, Popma JJ, Leon MB. Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. Intravasc Ultrasound Stud. 1997;95(7):1791–8.
    Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316(22):1371–5.
    Aoki J, Colombo A, Dudek D, et al. Persistent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation. Insights serial intravascular ultrasound analysis in the TAXUS II study. Circulation. 2005;112(25):3876–83.
    •• Hong S, Kim B, Shin D, et al. Effect of intravascular ultrasound–guided vs angiography-guided everolimus-eluting stent implantation: The ivus-xpl randomized clinical trial. JAMA 2015; 314(20). This randomized clinical trial is the most recent study showing the impact of IVUS on PCI optimization using second generation drug-eluting stent.
    • Abizaid A, Costa Jr JR, Bartorelli AL, et al. The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. Euro Intervention. 2015;10(12):1396–401. This study illustrates the importance of IVUS as a valuable tool for the on development implant of BVS.
    Abizaid A, Costa RA, Schofer J, et al. Serial multimodality imaging and 2-year clinical outcomes of the novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the treatment of single de novo coronary lesions. JACC: Cardiovasc Interv. 2016;9(6):565–74.
    Maresca D, Adams S, Maresca B, van der Steen AFW. Mapping intravascular ultrasound controversies in interventional cardiology practice. PLoS One. 2014;9(5), E97215.
    Intravascular Ultrasound (IVUS) - Global Trends, Estimates and Forecasts, 2012-2018 at- http://www.marketreportsworld.com/10079232 .
    Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2014;35(37):2541–619.
    Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. Circulation. 2011;124(23):e574–651.
    Mattos LA, Lemos Neto PA, Rassi Jr A, et al. Diretrizes da Sociedade Brasileira de Cardiologia. Intervenção Coronária Percutanea e Métodos Adjuntos Diagnósticos em Cardiologia Intervencionista (II Edicão - 2008). Arq Bras Cardiol. 2008;91(6 Supl.1):1–58.
    Nishioka T, Amanullah AM, Luo H, et al. Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity comparison with stress myocardial perfusion imaging. J Am Coll Cardiol. 1999;33(7):1870–8.
    Abizaid A, Mintz GS, Pichard AD, et al. Clinical, intravascular ultrasound, and quantitative angiographic determinants of the coronary flow reserve before and after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1998;82(4):423–8.
    Briguori C, Anzuini A, Airoldi F, et al. Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve. Am J Cardiol. 2001;87(2):136–41.
    Ben-Dor I, Torguson R, Gaglia M, et al. Correlation between fractional flow reserve and intravascular ultrasound lumen area in intermediate coronary artery stenosis. Euro Interv. 2011;7(2):225–33.
    Lee C-H, Tai B-C, Soon C-Y, et al. New set of intravascular ultrasound-derived anatomic criteria for defining functionally significant stenoses in small coronary arteries (results from Intravascular Ultrasound Diagnostic Evaluation of Atherosclerosis in Singapore [IDEAS] Study). Am J Cardiol. 2010;105(10):1378–84.
    • McDaniels MC, Eshtehardi P, Sawaya FJ, Douglas JJS, Samady H. Contemporary clinical applications of coronary intravascular ultrasound. JACC: Cardiovasc Interv. 2011;4(11):1155–67. This is a comprehensive review on IVUS, and also proposes a very useful algorithm to the assessment of moderate coronary lesions.
    Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary RevascularizationA Report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2009;53(6):530–53.
    Jang J-S, Song Y-J, Kang W, et al. Intravascular ultrasound-guided implantation of drug-eluting stents to improve outcome: a meta-analysis. JACC: Cardiovasc Interv. 2014;7(3):233–43.
    •• Steinvil A, Zhang Y-J, Lee SY, et al. Intravascular ultrasound-guided drug-eluting stent implantation: an updated meta-analysis of randomized control trials and observational studies. Int J Cardiol. 2016;216:133–9. This is the most recent meta-analysis about IVUS -guided drug-eluting stent PCI.
    Zhang Y-J, Farooq V, García-García HM, et al. Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients. Euro Interv. 2012;8(7):855–65.
    Ahn J-M, Kang S-J, Yoon S-H, et al. Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol. 2014;113(8):1338–47.
    Sbruzi G, Quadros AS, Ribeiro RA, et al. Intracoronary ultrasound-guided stenting improves outcomes: a meta-analysis of randomized trials. Arq Bras Cardiol. 2012;98(1):35–44.
    James MT, Samuel SM, Manning MA, et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis. Circ: Cardiovasc Interv. 2013;6(1):37–43.
    • Mariani Jr J, Guedes C, Soares P, et al. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: The MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial. JACC: Cardiovasc Interv. 2014;7(11):1287–93. A Brazilian study comparing IVUS-guided and angiography-guided PCI on high risk patients susceptible to contrast induced nephfropathy.
    Rodriguez-Granillo GA, Vos J, Bruining N, et al. Long-term effect of perindopril on coronary atherosclerosis progression (from the PERindopril’s Prospective Effect on Coronary aTherosclerosis by Angiography and IntraVascular Ultrasound Evaluation [PERSPECTIVE] Study). Am J Cardiol. 2007;100(2):159–63.
    Takagi T, Yoshida K, Akasaka T, et al. Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: a serial intravascular ultrasound study. J Am Coll Cardiol. 2000;36(3):731.
    Takagi T, Yamamuro A, Tamita K, et al. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study. Am Heart J. 2003;146(2):366.
    Britten MB, Zeiher AM, Schächinger V. Effects of cardiovascular risk factors on coronary artery remodeling in patients with mild atherosclerosis. Coron Artery Dis. 2003;14(6):415–22.
    Hong M-K, Park S-W, Lee CW, et al. Elevated homocysteine levels might be associated with coronary artery remodeling in patients with stable angina: an intravascular ultrasound study. Clin Cardiol. 2002;25(5):225–9.
    Sabaté M, Kay IP, de Feyter PJ, et al. Remodeling of atherosclerotic coronary arteries varies in relation to location and composition of plaque. Am J Cardiol. 1999;84(2):135–40.
    Gerstein HC, Ratner RE, Cannon CP, et al. Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease. The Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in Diabetes Patients With Cardiovascular History Trial. Circulation. 2010;121(10):1176–87.
    • Cavalcante R, Bittencourt MS, Pinheiro TL, et al. Validation of coronary computed tomography angiography scores for non-invasive assessment of atherosclerotic burden through a comparison with multivessel intravascular ultrasound. Atherosclerosis. 2016;247:21–7. A recent Brazilian study about on delineation of CCTA patterns of plaque burden based on IVUS standards.
    Falcão JLAA, Falcão BAA, Gurudevan SV, et al. Comparison between MDCT and Grayscale IVUS in a quantitative analysis of coronary lumen in segments with or without atherosclerotic plaques. Arq Bras Cardiol. 2015;104:315–23.
    Kornowski R, Mintz GS, Lansky AJ, et al. Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients. Am J Cardiol. 1998;81(11):1298–304.
    Weissman NJ, Sheris SJ, Chari R, et al. Intravascular ultrasonic analysis of plaque characteristics associated with coronary artery remodeling. Am J Cardiol. 1999;84(1):37–40.
    Jensen LO, Thayssen P, Mintz GS, et al. Intravascular ultrasound assessment of remodelling and reference segment plaque burden in type-2 diabetic patients. Eur Heart J. 2007;28(14):1759–64.
    Jiménez-Quevedo P, Suzuki N, Corros C, et al. Vessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes. A serial intravascular ultrasound analysis. Diabetes. 2009;58(1):209–14.
    Bayturan O, Tuzcu EM, Uno K, et al. Comparison of rates of progression of coronary atherosclerosis in patients with diabetes mellitus versus those with the metabolic syndrome. Am J Cardiol. 2010;105(12):1735–9.
    Federation ID. International Diabetes Federation Diabetes Atlas. 2016. http://www.idf.org/diabetesatlas (accessed 08/31/2016 2016).
    Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229–34.
    Schramm TK, Gislason GH, Køber L, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk. A population study of 33 million people. Circulation. 2008;117(15):1945–54.
    Carrozza JP, Kuntz RE, Fishman RF, Baim DS. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med. 1993;118(5):344–9.
    Abizaid A, Kornowski R, Mintz GS, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol. 1998;32(3):584.
    Elezi S, Kastrati A, Pache J, et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol. 1998;32(7):1866.
    Cutlip DE, Chauhan MS, Baim DS, et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol. 2002;40(12):2082.
    Kornowski R, Mintz GS, Kent KM, et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: a serial intravascular ultrasound study. Circulation. 1997;95(6):1366–9.
    Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients: The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1996;94(8):1818–25.
    Cassese S, Byrne RA, Tada T, et al. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart. 2014;100(2):153–9.
    Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol. 1996;27(3):528.
    Nishimoto Y, Miyazaki Y, Toki Y, et al. Enhanced secretion of insulin plays a role in the development of atherosclerosis and restenosis of coronary arteries: elective percutaneous transluminal coronary angioplasty in patients with effort angina. J Am Coll Cardiol. 1998;32(6):1624.
    Nishio K, Fukui T, Tsunoda F, et al. Insulin resistance as a predictor for restenosis after coronary stenting. Int J Cardiol. 2005;103(2):128.
    Sekiguchi M, Kurabayashi M, Adachi H, Hoshizaki H, Oshima S, Taniguchi K. Usefulness of insulin resistance measured by homeostasis model assessment in predicting restenosis after coronary stent placement in nondiabetic patients. Am J Cardiol. 2004;93(7):920.
    Reaven GM. Banting lecture 1988 Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–607.
    Reaven GM, Chen YDI. Insulin resistance, its consequences, and coronary heart disease: must we choose one culprit? Circulation. 1996;93(10):1780–3.
    Khaliq A, Johnson BD, Anderson RD, et al. Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation Study. Cardiovasc Endocrinol. 2015;4(2):45–52.
    Qiao Q, Pyorala K, Pyorala M, et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J. 2002;23(16):1267–75.
    The DECODE Study Group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001;161(3):397–405.
    Muhlestein JB, Anderson JL, Horne BD, et al. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J. 2003;146(2):351.
    Lima-Filho MO, Figueiredo GL, Foss-Freitas MC, Foss MC, Marin-Neto JA. Predictors of restenosis after percutaneous coronary intervention using bare-metal stents: a comparison between patients with and without dysglycemia. Braz J Med Biol Res. 2010;43:572–9.
    Lopes NH, Paulitsch FS, Pereira AC, et al. Impact of metabolic syndrome on the outcome of patients with stable coronary artery disease: 2-year follow-up of the MASS II study. Coron Artery Dis. 2008;19(6):383–8.